Tickwind
HoyOportunidadesMercadosChat con IA
ES
Iniciar sesiónRegistrarse
Tickwind

Lee cada tick. Ve hacia dónde sopla el mercado.

  • XInglés
  • TelegramChino
  • BoletínInglés

Producto

  • Mercados
  • Zonas temáticas
  • Todas las acciones
  • Comparar
  • Acciones en tendencia
  • Oportunidades
  • Noticias
  • Discusión
  • Lista de seguimiento
  • Novedades

Cuenta

  • Ajustes
  • Boletín
  • Para prensa e investigación
  • Servidor MCP
  • Contacto
  • Iniciar sesión
  • Registrarse
MercadosZonas temáticasTodas las accionesCompararAcciones en tendenciaOportunidadesNoticiasDiscusiónLista de seguimientoNovedadesAjustesBoletínPara prensa e investigaciónServidor MCPContactoIniciar sesiónRegistrarse

© 2026 Tickwind. No es asesoría de inversión.

Hecho para el inversor curioso.

Home/CRH/Filing changes

CRH — what changed in the latest 10-Q

A section-by-section comparison of CRH's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.

Comparing 10-Q · 2026-10-29 vs the prior 10-Q · 2026-07-30

SectionOutcomeAddedRemovedMinorUnchanged
MD&AText added/removed+42−32~8434
Market risk (Item 3)Text added/removed+3−2~56
Controls & proceduresText added/removed00~13
Legal proceedingsText added/removed+1−901
Other informationText added/removed00~10

Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.

Not shown (absent or not faithfully extractable): Risk factors

Representative excerpts

Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.

MD&A

Text added vs the prior filing · source: 10-Q · 2026-10-29

  • •Diluted Earnings Per Share (EPS) was $1.86 compared to $2.21. Diluted EPS pre-impairment* was $2.09 compared to $2.27.
  • •Net income was $2.5 billion compared with $2.8 billion, a decrease of $0.2 billion or 9%. Adjusted EBITDA*2was $5.9 billion, an increase of $0.2 billion, or 4%;
  • •The final tranche of the legacy share buyback program was completed on July 28, 2026, with $0.7 billion cash returned to shareholders for the nine months ended September 30, 2026, compared with $0.9 billion in the first nine months of the prior year. On October 29, 2026, CRH announced that its Boar…
  • For the nine months ended September 30, 2026, CRH completed 25 acquisitions for a total consideration of $1.7 billion, compared to $3.2 billion in the first nine months of the prior year.
  • On October 23, 2026, CRH completed its acquisition of Arcosa, a leading U.S. provider of aggregates and critical infrastructure products. Under the terms of the merger agreement, Arcosa stockholders received $150.00 per share in cash, for a total enterprise value of approximately $8.5 billion. CRH f…

Text removed vs the prior filing · source: 10-Q · 2026-07-30

  • •Diluted Earnings Per Share (EPS) was $2.21 compared to $1.94.
  • •Net income was $1.3 billion compared with $1.2 billion, an increase of $0.1 billion or 8%. Adjusted EBITDA*2was $3.2 billion, an increase of $0.3 billion, or 9%;
  • •Cash returned to shareholders through share buybacks was $0.6 billion for the six months ended June 30, 2026, in line with the comparable period in 2025. On July 28, 2026, the latest tranche of the share buyback program was completed, bringing year-to-date repurchases to $0.7 billion. As announced …
  • For the six months ended June 30, 2026, CRH completed 16 acquisitions for a total consideration of $1.2 billion, compared to $0.7 billion in the first six months of the prior year. The largest acquisition, which completed on May 29, 2026, was the acquisition of Axius Water for a total consideration …
  • On June 22, 2026, the Company announced a definitive agreement to acquire Arcosa, a leading U.S. provider of infrastructure-related materials, products and solutions, headquartered in Dallas, Texas, in an all-cash transaction for $150 per share reflecting a total enterprise value of approximately $8…

Market risk (Item 3)

Text added vs the prior filing · source: 10-Q · 2026-10-29

  • Cash and cash equivalents and restricted cash as of September 30, 2026, were $5.1 billion, compared to $4.1 billion as of December 31, 2025 and $4.3 billion as of September 30, 2025, which were all held on short-term deposits and investments.
  • As of September 30, 2026, the before-tax earnings and cash flows impact of a 100bps increase in interest rates, including the offsetting impact of derivatives, on the variable rate cash and debt portfolio would be approximately $18 million favorable ($24 million favorable as of December 31, 2025 and…
  • * Represents a non-GAAP financial measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 34 to 35.2

Text removed vs the prior filing · source: 10-Q · 2026-07-30

  • As of June 30, 2026, the before-tax earnings and cash flows impact of a 10 bps increase in interest rates, including the offsetting impact of derivatives, on the variable rate cash and debt portfolio would be approximately $14 million favorable ($24 million favorable as of December 31, 2025 and $6 m…
  • * Represents a non-GAAP financial measure. See the discussion within 'Non-GAAP Reconciliation and Supplementary Information' on pages 31 to 33.2

Legal proceedings

Text added vs the prior filing · source: 10-Q · 2026-10-29

  • There have been no material changes with respect to the risk factors disclosed in 'Item 1A. Risk Factors' of our 2025 Form 10-K and our other filings with the SEC.

Text removed vs the prior filing · source: 10-Q · 2026-07-30

  • The following is an update to the risk factors set forth in our 2025 Form 10-K for the fiscal year ended December 31, 2025. Other than the following update, there have been no material changes with respect to the risk factors disclosed in 'Item 1A. Risk Factors' of our 2025 Form 10-K.
  • CRH engages in acquisition and divestiture activity as part of active portfolio management, and this portfolio management activity presents risks around due diligence, execution, and integration of assets. Additionally, the Company may be liable for liabilities of companies it has acquired or divest…
  • The Company’s acquisition strategy depends on successfully identifying and acquiring suitable assets at prices that satisfy our stringent cash flow and return on investment criteria. The Company may not be able to identify such companies, and, even if identified, may not be able to acquire them beca…
  • In addition, the Company’s ability to realize the expected benefits from acquisitions depends in part on its ability to integrate newly-acquired businesses. If the Company fails to integrate acquisitions, it may not achieve expected growth synergies or financial, operating or other benefits, and it …
  • The Company may also, from time to time, enter into larger-scale transactions. For example, on June 22, 2026, the Company announced entry into a definitive agreement to acquire Arcosa, which is subject to the approval of Arcosa’s stockholders, regulatory approvals and other customary closing conditi…

How to read Risk Factors (Item 1A) in a 10-Q

A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:

  • Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
  • Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
  • Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.

This describes the filing structure only — it is never a judgement on whether risk went up or down.

Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice

More on CRH

CRH overviewCRH quant ratingCRH fair value (DCF)CRH vs peersCRH revenue historyCRH AI deep research